Doctors Push FDA to Ban Benadryl Over Brain Damage Risks
Medical experts call for removal of diphenhydramine from US shelves, citing severe side effects including dementia risk, impaired driving, and thousands of hospitalisations annually.
Category : Pharmaceuticals
FDA Reviews Zyn Advertising Proposal for Reduced Risk Claims
The FDA is evaluating whether to allow Philip Morris to market Zyn nicotine pouches as a less harmful alternative to cigarettes, with a panel of experts weighing the evidence.
Acid Reflux Drugs Cleared of Stomach Cancer Risk
A major study published in The BMJ finds no link between long-term use of proton pump inhibitors and gastric adenocarcinoma, challenging earlier research.
Subtle Dementia Sign: Not Memory Loss
A leading expert explains a subtle, often-missed indicator of early dementia that manifests in everyday life, distinct from typical memory issues.
Drug Could Delay Rheumatoid Arthritis by Years, Study Finds
A new study from King's College London reveals that abatacept could delay rheumatoid arthritis onset by up to four years in high-risk patients, offering hope for improved quality of life.
South Carolina Leads US in GLP-1 Weight-Loss Drug Searches
New analysis reveals South Carolina tops US states for searches about Ozempic-style medications, with high obesity and diabetes rates potentially driving interest among aging populations.
GSK buys RAPT in $2.2bn food allergy drug deal
GSK acquires US biotech RAPT Therapeutics for $2.2bn, gaining a potential blockbuster treatment for severe food allergies like nuts and milk. Read the full story on the strategic move.
Boots' 17p plant sterol tablets slash cholesterol
Boots' own-brand Max Strength Plant Sterols, on sale for just 17p per capsule, are clinically proven to help lower LDL 'bad' cholesterol. Discover how they work and what shoppers say.
GSK buys Rapt Therapeutics in £1.6bn food allergy deal
Pharmaceutical giant GSK has agreed a £1.6bn acquisition of Rapt Therapeutics, gaining rights to a promising new treatment for food allergies. The deal is set to complete in early 2026.
GLP-1 Drugs Mask Deeper Body Image Crisis, Warns Expert
Psychotherapist Susie Orbach argues new weight-loss injections fail to address the root causes of troubled eating, fuelling profits for food and beauty giants. Read the full analysis.
Acne Drug Spironolactone: NHS Warning on Side Effects
Experts issue a vital warning about Spironolactone side effects for acne treatment. Learn about risks, foods to avoid, and NHS safety advice. Consult your GP for personalised guidance.
NHS issues urgent atorvastatin warning over drug interactions
The NHS cautions Brits taking atorvastatin about potentially dangerous interactions with other common medications, including antibiotics and blood thinners. Know the serious side effects and consult your GP.
The severe Ozempic side effects not shown on Instagram
An investigation into the hidden costs of GLP-1 'miracle drugs' like Ozempic reveals severe side effects including stomach paralysis and cyclical vomiting, as patients become part of a rapid healthcare experiment. Read the full story.
Mum finds £29 solution for teen's acne heartbreak
A 'heartbroken' mum found a dermatologically-tested skincare solution for her teen's blemishes. The £29 serum, from brand 47 Skin, has transformed confidence and saved family memories.
FDA's Fast-Track Drug Scheme Sparks Legal Alarm
The FDA's expedited drug approval programme, promising decisions in one month, faces intense scrutiny over legal authority and political interference. Read the full investigation.
FDA Fast-Track Programme Sparks Legal and Safety Fears
An FDA plan to slash drug review times is causing turmoil, with staff fearing political interference and legal risks. Key officials have resigned over authority concerns.
Generic Ozempic Drugs to Flood Market, Cutting Prices
Patents on semaglutide, the key ingredient in Ozempic, are expiring globally, paving the way for affordable generic versions. This could reshape obesity treatment and challenge Novo Nordisk's dominance. Discover the implications.
Trump's Healthcare Plan Unveiled, Experts Alarmed
Donald Trump has released his long-awaited healthcare framework, but experts warn it lacks crucial detail and could increase the number of uninsured Americans. Read the full analysis.
Nurse charged over counterfeit Ozempic injections
A Chicago nurse faces federal charges for allegedly administering counterfeit Ozempic. Discover the health risks and legal consequences of the illegal weight-loss drug trade.
Trump Announces New US Healthcare Plan with Direct Payments
President Trump's new healthcare proposal aims to slash premiums via direct payments and a crackdown on pharmacy managers. Could this reshape US health costs?
FDA drops suicide warnings from weight loss drugs
US regulators have ordered the removal of suicide risk warnings from Wegovy and Zepbound labels after a major review of 91 studies found no increased risk. Read the full analysis.
Ozempic Revolution Explored in New Book 'Off the Scales'
Reuters journalist Aimee Donnellan's new book delves into the social and scientific saga of GLP-1 drugs like Ozempic, challenging obesity stigma. Read the full review.
Mounjaro user must pay £200 monthly for life after weight gain
Kelly Parish, 32, tried to quit weight loss drug Mounjaro but regained 9lbs in weeks. She now faces a lifelong £200 monthly cost to maintain her health and size 12 figure. Read her story.
Gates Foundation Plans $9bn Spend and Staff Reductions
The Gates Foundation will spend a record $9 billion in 2026 while cutting up to 500 jobs. The move follows its plan to close in 2045 and aims to maximise impact in global health.
Eli Lilly's 'GLP-3' Drug More Effective Than Current Jabs
Eli Lilly's new triple-hormone weight loss drug, retatrutide, led to 29% body weight loss in trials, outperforming current GLP-1 medications. Explore the potential and risks of this next-generation treatment.
Foods to Avoid on Ozempic and Mounjaro, Experts Say
Millions on GLP-1 drugs like Ozempic face digestive woes. Nutrition experts reveal the five food groups that dramatically worsen nausea, bloating, and heartburn. Learn how to adjust your diet for better results.
Supplement Recall Over Illegal Drug Ingredients
Modern Warrior's 'Ready' supplements are recalled after FDA testing reveals undeclared tianeptine, 1,4-DMAA, and aniracetam. Stop using the product immediately.
Foods to avoid on Ozempic and Mounjaro to stop side effects
Experts reveal the foods that worsen side effects like nausea and constipation for millions on GLP-1 weight loss drugs. Learn what to cut from your diet for better results.
Supplement Recall Over Hidden Illegal Drug Ingredients
The FDA announces a major recall of Modern Warrior's 'Ready' supplements after testing revealed undeclared tianeptine, 1,4-DMAA, and aniracetam. Consumers are urged to stop use immediately.
Stronger addiction warnings for common UK prescription drugs
UK regulator MHRA mandates clearer addiction warnings on gabapentinoids, benzodiazepines, and Z-drugs. 4.5 million in England prescribed these medicines annually. Learn the risks and safe use.
Page 2 of 16